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Growing awareness of the central role of the E4orf6 protein in regulating the infectious cycle of human adenoviruses has
led to greatly intensified efforts to define its functions and mechanisms of action. Many workers employ cDNAs to generate
plasmid or viral vectors to express E4orf6 in the absence of other viral products. In addition to the normal 34-kDa product,
such vectors consistently produce a polypeptide of about 8 kDa. In the present report we show that this protein is produced
by an aberrant mRNA utilizing the 59 splice donor site used normally by the virus to produce the E4orf6/7 product, which
shares 58 residues with E4orf6. This amino terminal coding sequence is linked to a 39 sequence via a novel splice acceptor
site in an alternative reading frame of the E4orf6 cDNA. The 59 donor site was altered by PCR-directed mutagenesis to yield
a construct that produces high levels of E4orf6 in the absence of the 8-kDa polypeptide. This construct should eliminate some
of the problems encountered previously using the wild-type E4orf6 coding sequence. © 2000 Academic Press
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hThe early region 4 (E4) transcription unit of human
adenoviruses produces at least seven products through
extensive RNA splicing (1). The 34-kDa polypeptide of E4
open reading frame 6 (E4orf6) performs several functions
critical for viral replication. Another transcript encodes a
related product, E4orf6/7, which shares 58 amino termi-
nal residues with E4orf6 and functions to bind to and
facilitate the activity of transcription factor E2F (2–4).
E4orf6 is a nuclear protein that contains both a nuclear
localization signal (NLS) and an amphipathic arginine-
rich a-helical nuclear retention signal (NRS) believed to
arget E4orf6 to the nucleus (5, 6). In addition, a nuclear
xport signal (NES) is present that has homology to the
IV Rev protein NES (7) and is believed to mediate
uclear-cytoplasmic shuttling of E4orf6 (5). E4orf6 was
ecently shown to be a zinc-binding protein, and muta-
ion of several of the conserved cysteine and histidine
esidues inactivate E4orf6 functions (8). Although E4orf6
an interact directly with the cellular p53 tumor suppres-
or (9, 10) and block its ability to transactivate some
arget promoters (9), it derives much of its biological
ctivity when complexed with the early region 1B 55-kDa
E1B-55K) protein (11–13). E4orf6/E1B-55K complexes
re also involved in the selective transport of viral
RNAs to the cytoplasm late in the infectious cycle
1 Present address: Cold Spring Harbor Laboratory, P.O. Box 100, Cold
pring Harbor, NY 11724.
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (514) 398-7384. E-mail: branton@med.mcgill.ca.
26314–17). This complex also enhances viral mRNA trans-
ation (18, 19), at least in part by this selective transport
unction. Finally, E4orf6/E1B55K complexes induce the
egradation of the p53 tumor suppressor (10, 20–22).
his function is critical, as expression of the early region
A (E1A) protein activates and stabilizes p53 (23, 24), an
ffect that could lead to premature apoptosis of the
nfected cell. Inhibition and degradation of p53 probably
t least partially underlie the ability of E4orf6 to enhance
ransformation by E1A and other oncogenes (20, 25, 26).
4orf6 and E4orf6/7 were recently found to associate
ith DNA-PK and inhibit double-strand break repair (27),
hus preventing the formation of adenovirus genome
oncatamers during replication (28). Several of these
unctions may involve complex formation by E4orf6 with
series of cellular proteins of as yet unidentified cellular
roteins (29).
A number of laboratories study the functions of E4orf6
n the absence of other adenovirus proteins using either
lasmid expression vectors (19) or an adenovirus vector
10) containing E4orf6 cDNAs. We have noticed that, in
ddition to the 34-kDa E4orf6 product, a major protein of
bout 8 kDa is produced from these cDNAs. Expression
f this species could complicate interpretation of studies
n E4orf6 if this protein possesses biological activity. In
he present studies we have used a series of E4orf6
eletion mutants to identify the origin of the 8-kDa spe-
ies and have generated a new construct that produces
igh levels of E4orf6 in the absence of this polypeptide.Previous studies indicated that the 8-kDa species was
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264 RAPID COMMUNICATIONdetected using rabbit polyclonal serum specific for the
amino terminus of E4orf6, but not with a serum prepared
against the carboxy terminal region (29). These results
suggested that the 8-kDa species contains amino termi-
nal E4orf6 sequences. Our group has made a large
series of small in-frame E4orf6 deletion mutants to un-
dertake detailed functional mapping of E4orf6. Construc-
tion of such mutants involved both restriction enzyme
digestion and PCR-mediated mutagenesis and has been
described in detail elsewhere (E. Querido, S. W.-L. Thirl-
well, M. R. Morisson, H. Chu-Pham-Dang, D. Boivin, and
P. E. Branton, submitted for publication). Briefly, the cDNA
for human adenovirus type 5 (Ad5) E4orf6 was cloned
into pcDNA3 vector DNA in which expression of E4orf6
occurs from the cytomegalovirus (CMV) promoter. All
mutants were present in this vector. The internal deletion
mutants were prepared by a four-oligonucleotide PCR
method (30). The E4orf6sf mutant was also prepared by
this method using appropriate oligonucleotides. The
G198A, R240E/R241E, and E255A/E256A point mutants
were made by three-oligonucleotide PCR amplification
and dl1-13 by a two-oligonucleotide PCR amplification.
Mutant dl275–294 was obtained by first engineering stop
codons in each of the three reading frames at the car-
boxy terminus of E4orf6, followed by digestion with the
unique cutter, BSSHII, and then blunt end ligation. All
E4orf6 mutants were verified by sequencing. Point mu-
tants affecting the NES (L90A/I92A) and the NRS (R248E),
as well as an NLS/NRS double mutant (L90A/I92A/
R248E), were generously provided by Matthias Dobbel-
stein (5).
Plasmid DNA encoding wild-type and mutant forms of
E4orf6 were introduced into H1299 cells by lipofection
and, following separation by SDS–polyacrylamide gel
electrophoresis (SDS-PAGE) and transfer to nitrocellu-
lose filters, E4orf6-related products were detected by
Western immunoblotting using E4orf6-N serum, which
recognizes the amino terminus of E4orf6 (29). Figure 1
shows the results of such an experiment. Clearly all
cDNAs expressed high levels of E4orf6 protein. In addi-
tion to full-length E4orf6, two different cDNAs containing
wild-type E4orf6 also expressed the 8-kDa species
(lanes 19 and 24). Extracts from cells lipofected with
empty pcDNA3 vector contained neither product (lane
23). The 8-kDa species was also detected with cDNAs
expressing E4orf6 containing various point mutations
(lanes 16–18 and 20–22), including those affecting the
NRS (R240E/R241E, lane 17; R248E, lane 21) and the NES
(L90A/I92A, lane 20; L90A/I92A/R248E, lane 22). The de-
letion mutants were more informative as to the origin of
the 8-kDa species. It was detected with dl65–82 (lane 6)
and all deletion mutants toward the carboxy terminus
(dl83–94, etc., lanes 6–14), except dl249–274 (lane 15,
see below); however, it was absent with deletion mutants
dl1–13, dl13–23, dl23–34, dl35–43, and dl49–69 (lanes
1–5, respectively). These results indicated that the 8-kDaspecies must contain a maximum of 69 amino terminal
residues of E4orf6.
The most likely explanation for the appearance of the
8-kDa species was that it is created from the strong
splice donor site for the mRNA encoding E4orf6/7, which
shares 58 amino terminal residues with E4orf6. Figure
2A shows the amino and carboxy terminal amino acid
and nucleotide sequences for E4orf6. E4orf6 contains a
perfect C/A-A-G-G-T-A/G-A-G-T donor site starting at nu-
cleotide A172, in which the splice occurs following nu-
cleotide 174 to yield a 58-residue amino terminal region.
Analysis of the E4orf6 sequence indicated that one likely
splice acceptor exists that conforms to the consensus
sequence T/C 3 11bp–N-C/T-A-G-G, located at C792-
A793-G794-G795 (see Fig. 2A). This site also seemed the
most probable acceptor because mutant dl249–274,
which lacks this region, does not produce the 8-kDa
polypeptide (Fig. 1, lane 15). This region includes nucle-
otides 792–795, which are components of the codons for
residues Cys-264 and Arg-265 within the 249–274 dele-
tion (see Fig. 2A). Use of such a splice acceptor would
encode an additional 24 residues in an alternate reading
FIG. 1. Analysis of the synthesis of E4orf6-related proteins using
cDNAs expressing wild-type and mutant E4orf6 products. H1299 cells
were lipofected according to the Gibco/BRL lipofectin protocol. Whole
cell extracts were prepared and 40 mg of protein was analyzed by
SDS–PAGE using gels containing either 14 or 15% polyacrylamide. After
transfer to nitrocellulose, samples were immunobloted using 1808
E4orf6 N-terminal serum, as described previously (29).frame from that of E4orf6 before terminating at a TGA at
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265RAPID COMMUNICATIONnucleotides 868–870. The molecular mass of this hypo-
thetical 82-residue protein would be about 8 kDa.
To determine whether this process was indeed the
origin of the 8-kDa protein, a series of point mutations
was introduced into the third nucleotide of the codons for
Asn-58 and Val-59, and the entire codon for Ser-60 was
altered to an alternative codon sequence (see Fig. 2B).
Plasmid cDNAs encoding wild-type E4orf6, dl275–294,
and the E4orf6 “splice-fix” mutant (E4orf6sf) were lipo-
fected into cells and E4orf6-related polypeptides again
detected by Western blotting using E4orf6-N serum. Fig-
ure 1 shows that the 8-kDa species was present with
wild-type E4orf6 cDNA (lane 25) but absent with the
E4orf6sf (SF) plasmid (lane 27). Thus it was likely that the
polypeptide predicted in Fig. 2 represents the 8-kDa
species. E4orf6 mutant dl275–294 (lane 26) produces a
7.5-kDa species at very low levels (not evident in the
exposure shown in Fig. 1). This 72-amino-acid polypep-
tide would terminate at an alternative reading frame stop
codon present in this mutant. In addition, Fig. 1 (compare
lanes 25 and 27) shows that higher amounts of full-length
E4orf6 are produced with E4orf6sf.
The results from this study have determined the origin
FIG. 2. Analysis of splice sites in Ad5 E4orf6 cDNA. (A) Ad5 E4orf6
E4orf6 have been included and the central region omitted. The underline
positions are indicated above the sequence. (B) Mutation of the 59 sp
to abolish production of the 8-kDa product have been illustrated.of the 8-kDa species that is synthesized from E4orf6 ncDNAs. It should be noted that this 8-kDa species is not
produced at all from adenoviruses containing genomic
viral DNA (29), and thus it appears that the normal 39
splice acceptor site used for E4orf6/7 mRNA is highly
preferred. Such would be predicted as this site contains
a more or less perfect acceptor sequence, whereas that
at nucleotides 792–795 is less than optimal. Use of the
altered E4orf6sf cDNA sequence would eliminate syn-
thesis of this unnatural E4orf6-related product and elim-
inate possible confusion in analyses of E4orf6 function in
studies employing E4orf6 cDNAs. Both in vitro and in vivo
inding studies have shown that E4orf6/7, which con-
ains the 58 amino terminal residues of E4orf6, is able to
ind E1B-55K (13); however, we have recently found that
he minimal region of E4orf6 required to bind E1B-55K is
ocated between residues 39 and 107 (Querido et al.,
ubmitted). These results leave open the possibility that
he 8-kDa E4orf6-related product could interact with E1B-
5K. In addition, the interaction of E4orf6 with several
ther proteins, including p53 (9), DNA-PK (27), and an
dditional multiprotein complex (29), could be affected.
hus it would be preferable to conduct future functional
tudies with cDNAs that express higher levels of only the
d protein sequence. The 59 amino and 39 carboxy sequences of Ad5
pairs are those that encode the 8-kDa product. Nucleotide/amino acid
or sequence. Bases changed in E4orf6sf “splice-fix” cDNA sequenceDNA an
d base
lice donormal E4orf6 product.
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